The Health Resources and Services Administration has overseen the 340B Drug Pricing Program since its creation in 1992. That ...

As a result of Secretary Kennedy’s recently announced cuts, CMS will have fewer staff on board than it did in 2015, despite ...

CMS is exploring a number of new tech initiatives to make it easier for providers and patients to access data, including a ...

HHS has proposed oversight of the 340B drug pricing program to the Centers for Medicare & Medicaid Services as part of a broader reorganization.  The move, initially referenced in a preliminary memo ...

The Trump administration has issued new draft guidance for the third cycle of Medicare drug price negotiations. The proposals seek to boost transparency in the program and put a focus on ...

The Centers for Medicare & Medicaid Services said this week that it plans to continue rolling out a $75 million nursing home ...

The Centers for Medicare & Medicaid Services May 27 announced it will increase oversight of states to prevent the misuse of ...

The guidance aims to increase program transparency, prioritize the selection of drugs that cost Medicare the most and ensure fair pricing does not hinder pharmaceutical innovation, the agency said ...

CMS draft guidance includes Medicare Part B drugs in 2026 price negotiations, with new prices set for 2028. Public comment period on CMS proposal is open until June 26, 2025. Get access to the ...

Just 12,000 of the nearly 250,000 newly eligible Georgians ultimately received Medicaid, the public health insurance program for the poor and disabled, well short of the state’s initial 50,000 goal.

CMS added that feature to the Medicare Shared Savings Program last year and included it in the ACO Primary Care Flex model that launched in January. ACOs and their participants welcomed those ...

Medicaid law requires states to finance at least 40 percent of the program, but as states invest more, the federal government will match the contributions. States can pay for their share through ...